Exome Pool-Seq in neurodevelopmental disorders.

Area of Science:

• Genetics
• Genomics
• Molecular Biology

Background:

• High-throughput sequencing is crucial for identifying disease genes, especially in complex conditions.
• Current sequencing methods can be expensive and time-consuming for large patient cohorts.
• Neurodevelopmental disorders (NDDs) are often genetically heterogeneous, posing challenges for gene discovery.

Purpose of the Study:

• To evaluate Exome Pool-Seq as an economical and rapid screening technology for NDDs.
• To identify novel disease-causing variants in NDDs using a pooled sequencing approach.
• To assess the cost-effectiveness and efficiency of Exome Pool-Seq compared to individual exome sequencing.

Main Methods:

• Applied Exome Pool-Seq to pool DNA from 96 individuals with NDDs into eight pools of 12 samples.
• Utilized Illumina sequencing technology for high-throughput data generation.
• Analyzed sequencing data to identify variants within established and candidate NDD genes.

Main Results:

• Identified 27 potentially functional variants in 96 cases, with 25 in known NDD genes and 2 in candidate genes.
• Discovered a novel de novo loss-of-function variant in LRRC7, not previously linked to NDDs.
• Achieved a 28% variant detection rate, comparable to individual exome analysis, but with over 85% cost reduction.

Conclusions:

• Exome Pool-Seq is a highly effective, cost-efficient, and flexible screening tool for large-scale genetic studies in heterogeneous disorders like NDDs.
• This method significantly reduces costs associated with genetic analysis in large cohorts.
• Exome Pool-Seq enables flexible data re-analysis, offering advantages over other large-scale sequencing approaches.